EUROPREVAL

Cancer prevalence in Northern Europe: the EUROPREVAL study 
Möller T.; Anderson H.; Aareleid T.; Hakulinen T.; Storm H.; Tryggvadottir L.; Corazziari I.; Mugno E. 
Annals of Oncology 2003,14:946-957

Cancer prevalence in the UK: results from the EUROPREVAL study 
Forman D.; Stockton D.; Møller H.; Quinn M.; Babb P.; De Angelis R.; Micheli A. 
Annals of Oncology 2003,14:648-654

Cancer prevalence in central Europe :the EUROPREVAL study 
Lutz J.M.; Francisci S.; Mugno E.; Usel M.; Pompe-Kirn V.; Coebergh J.W.; 
Bieslka-Lasota M.; On behalf of the EUROPREVAL Working Group. 
Annals of Oncology 2003,14:313-322

A comparative analysis of cancer prevalence in cancer registry areas of France, Italy and Spain 
Verdecchia A.; Micheli A.; Colonna M.; Moreno V.; Izarzugaza M.I.; Paci E. 
Annals of Oncology 2002,13:1128-1139

Cancer Prevalence in European Registry Areas 
Micheli A.; Mugno E.; Krogh V.; Quinn M.J.; Coleman M.; Hakulinen T.; Gatta G.; 
Berrino F.; Capocaccia R. 
Annals of Oncology 2002,13:840-865

Measuring cancer prevalence in Europe: the EUROPREVAL Project 
Capocaccia R.; Colonna M.; Corazzieri I.; De Angelis R.; Francisci S.; Micheli A.; Mugno E. 
Annals of Oncology 2002,13:831-839